Cytrellis Adds Micro-Coring Training to Miami Nurse Practitioners

By Tom Whitfield

The ellacor training program runs for 12 weeks, combining 40 classroom hours with 20 supervised clinical hours for nurse practitioners in the University of Miami’s Aesthetic Medicine Certificate Program.

The initiative comes through a new partnership between Cytrellis Biosystems and the Academy for Aesthetics and Anti-Aging Studies, or AFAAAS. It introduces the ellacor system through practical, supervised experience with nonsurgical skin restoration techniques.

The collaboration describes ellacor as a device that uses Micro-Coring Technology to extract microscopic portions of skin without thermal energy. Its stated treatment targets are moderate to severe wrinkles and skin laxity.

What does the training include?

The course has three practical components. Together, they place device exposure inside a 12-week certificate pathway.

• 40 classroom hours of instruction within the 12-week program.
• 20 supervised clinical hours offering practical experience with ellacor and nonsurgical skin restoration.
• Equipment and professional demonstrations from Cytrellis for three annual student cohorts.

The sequence embeds supervised clinical contact inside formal certificate training rather than leaving device exposure to informal observation. The aim is to give nurse practitioners familiarity with the system before they enter independent practice.

How does ellacor work?\n

Micro-Coring Technology extracts microscopic portions of skin without thermal energy. Cytrellis presents this approach as nonsurgical skin restoration for moderate to severe wrinkles and skin laxity.

Those are device claims, not clinical efficacy findings. The announcement reports no patient cohort, comparison group, measured endpoint, follow-up period or numerical change in wrinkles or laxity. It also provides no regulatory clearance or approval details.

Who does the partnership bring together?\n

The arrangement joins Cytrellis, AFAAAS and the University of Miami program. AFAAAS collaborates with Cytrellis to introduce ellacor into certificate training for participating nurse practitioners. Cytrellis contributes the equipment and professional demonstrations, while supervised clinical training supplies the practical setting.

For Cytrellis, the partnership expands professional exposure to its technology and strengthens relationships with future aesthetic practitioners. It also supports specialized clinical education that helps healthcare professionals become familiar with emerging treatment options.

Why does device-led training matter?\n

The stated rationale rests on three developments:

• Micro-coring education: Specialized curricula built around micro-coring systems can help device makers embed emerging aesthetic technologies directly in professional training.
• Nonsurgical skin restoration: Demand for wrinkle and laxity treatment without thermal energy opens a market for minimally invasive platforms that seek visible outcomes with reduced procedural intensity.
• Practitioner-led device adoption: Hands-on exposure during certification creates a pathway for aesthetic technologies to build credibility among nurse practitioners before clinical use.

That arrangement gives device companies a direct route into professional education. It also supports the broader shift toward technology-enabled, procedure-specific healthcare training.

Which sectors does the partnership touch?\n

The initiative connects three areas:

• Aesthetic medicine: Advanced device training combines clinical credentialing, experiential learning and next-generation skin-treatment systems.
• Medical devices: Education partnerships give manufacturers a channel to familiarize future providers with proprietary platforms and treatment protocols.
• Healthcare education: Certificate programs that integrate supervised use of specialized equipment support more technology-enabled, procedure-specific training.

The arrangement embeds a proprietary platform within professional education. It also gives learners supervised exposure to equipment they may use in aesthetic practice.

What remains unproven?\n

The partnership can improve familiarity, but it does not establish comparative efficacy, safety or regulatory status. The announcement cites no study design, patient numbers, adverse-event data, treatment schedule or long-term follow-up. It also gives no launch date, tuition, certification criteria or criteria for independent use.

That distinction matters because the target indications—moderate to severe wrinkles and skin laxity—remain claims attached to the device. No trial evidence in the announcement shows how much either outcome improves, how long results last or how the procedure compares with other nonsurgical options.

For Cytrellis, the next test is whether the three annual cohorts convert supervised exposure into broader professional use and sustained relationships with aesthetic practitioners. For AFAAAS and the University of Miami, the test is whether device-specific education becomes a repeatable feature of certificate training. The instructional structure now exists; clinical adoption and outcome evidence remain open.